Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial is a research paper published in Age and Ageing (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
ASPREE
Grant: U01AG029824
ASPREE
Grant: U19AG062682
National Institutes of Health
Grant: 334047
Randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged.
National Institutes of Health
Grant: 1127060
ASPREE Completion Project
National Institutes of Health
Grant: 5U19AG062682-04
ASPirin in Reducing Events in the Elderly - eXTension
National Institutes of Health
Grant: 4U01AG029824-06
ASPirin in Reducing Events in the Elderly
National Health and Medical Research Council
Monash University and the Victorian Cancer Agency
National Institute on Ageing
National Cancer Institute
FWCI
0.30
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals